At HORAIZON, we are committed to provide personalized treatment and preventive care through advanced technology. By collaborating with our customers we examine individual microbial profiles, we enhance disease diagnosis and tailor treatments to each person’s unique needs.
Traditional microbiome analysis is often a time-consuming and costly process, requiring specialized equipment and expert teams. Results can take 2-3 weeks to process, which could delay critical interventions. In contrast, Microbeapp delivers rapid results within seconds using just a digital photo of a small fecal sample, making the process hassle-free, cost-effective, and reliable.
Our platform is built from the ground to help people make informed decisions about their health with just one click. Microbeapp combines your microbiome data with nutritional insights to give you a clear picture of your health. We assess key microbial biomarkers, including microbial diversity and the following key groups:
Visual elements like speedometers and gauges highlight which aspects of your gut microbiome are resilient or at risk, while also showing whether your microbial health is improving or declining. Like that, through precise microbiome analysis, we are able to tackle and transform your gut health.
Our platform integrates various data sources, from diverse human populations, to build and refine state-of-art deep learning models of gut health. By examining microbial interactions and leveraging these comprehensive insights, we develop targeted dietary recommendations that optimize individual health outcomes while addressing specific health concerns. Microbeapp’s innovative use of non-invasive technology ensures that our analyses are both accessible and efficient.
Microbeapp is designed with a robust and scalable technology that uses cutting edge and accurate image analysis. Our goal is to accelerate the delivery of superior solutions, enhancing microbial health and wellbeing more efficiently for those who need it.
Using the Microbeapp we aim to provide immediate feedback on how their diet influences their microbiome, guiding them toward healthier choices.
The Epigenetics Project is a groundbreaking initiative aimed at transforming the treatment of Crohn’s Disease.
This collaborative project is focused on developing a regenerative therapy for patients with ischemic heart disease.
Our company is collaborating with the University of Amsterdam to address the critical challenge of Late-Onset Neonatal Sepsis (LONS).
For any questions, additional information, or if you're interested in exploring commercial opportunities, please contact us.
Horaizon.ai © 2025 All Rights Reserved
